Wednesday, May 16, 2012

More on Alzheimer's

The New York Times reported today on a clinical trial of experimental drug called Crenezumab that could delay the appearance of symptoms in a family in Colombia with a genetic history or early-onset Alzheimer's Disease.

The drug is currently in two trials, but both of them involve people who are already showing symptoms.  The Colombian trial will involve family members who have (and don't have, for control's sake) the gene in question.

There are still a lot of questions and much remains to be seen, but this is promising research!

No comments:

Post a Comment